[go: up one dir, main page]

SI1634595T1 - N-fenilbenzamidni derivati kot zdravila za zdravljenje kronične obstruktivne pljučne bolezni (KOPB) - Google Patents

N-fenilbenzamidni derivati kot zdravila za zdravljenje kronične obstruktivne pljučne bolezni (KOPB)

Info

Publication number
SI1634595T1
SI1634595T1 SI200430892T SI200430892T SI1634595T1 SI 1634595 T1 SI1634595 T1 SI 1634595T1 SI 200430892 T SI200430892 T SI 200430892T SI 200430892 T SI200430892 T SI 200430892T SI 1634595 T1 SI1634595 T1 SI 1634595T1
Authority
SI
Slovenia
Prior art keywords
hydrogen
copd
pulmonary disease
chronic obstructive
obstructive pulmonary
Prior art date
Application number
SI200430892T
Other languages
English (en)
Inventor
Lucio Claudio Rovati
Antonio Giordani
Gianfranco Caselli
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Publication of SI1634595T1 publication Critical patent/SI1634595T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI200430892T 2004-08-19 2004-08-19 N-fenilbenzamidni derivati kot zdravila za zdravljenje kronične obstruktivne pljučne bolezni (KOPB) SI1634595T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04019648A EP1634595B1 (en) 2004-08-19 2004-08-19 N-Phenylbenzamide derivatives as drugs for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Publications (1)

Publication Number Publication Date
SI1634595T1 true SI1634595T1 (sl) 2008-12-31

Family

ID=34926220

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200430892T SI1634595T1 (sl) 2004-08-19 2004-08-19 N-fenilbenzamidni derivati kot zdravila za zdravljenje kronične obstruktivne pljučne bolezni (KOPB)

Country Status (12)

Country Link
US (1) US7482371B2 (sl)
EP (1) EP1634595B1 (sl)
JP (1) JP4987268B2 (sl)
AT (1) ATE404195T1 (sl)
AU (1) AU2005203706B2 (sl)
CA (1) CA2514373C (sl)
DE (1) DE602004015788D1 (sl)
DK (1) DK1634595T3 (sl)
ES (1) ES2311771T3 (sl)
PL (1) PL1634595T3 (sl)
PT (1) PT1634595E (sl)
SI (1) SI1634595T1 (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1978955A1 (en) * 2006-01-06 2008-10-15 Boehringer Ingelheim International GmbH New pharmaceutical compositions based on anticholinergics and andolast
EP1845093B1 (en) 2006-04-10 2009-06-10 Rottapharm S.p.A. A new crystalline and stable form of andolast
DE602006021638D1 (en) * 2006-07-31 2011-06-09 Rottapharm Spa Kombination aus andolast/glucocorticoiden
JP5459827B2 (ja) 2009-03-13 2014-04-02 株式会社Ｌｔｔバイオファーマ 慢性閉塞性肺疾患改善剤
CA2812184A1 (en) * 2010-09-17 2012-03-22 Dundalk Institute Of Technology Anthraquinone compounds and their uses
EP2439200A1 (en) * 2010-09-17 2012-04-11 Dundalk Institute of Technology Anthraquinone compounds and their uses
WO2013137009A1 (ja) 2012-03-14 2013-09-19 株式会社Ｌｔｔバイオファーマ 慢性閉塞性肺疾患改善剤
WO2015122031A1 (ja) 2014-02-17 2015-08-20 株式会社Ｌｔｔバイオファーマ メペンゾラート光学活性体及びそれを有効成分とする慢性閉塞性肺疾患改善剤
JP6693943B2 (ja) 2015-03-02 2020-05-13 株式会社Ｌｔｔバイオファーマ キヌクリジン誘導体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1232252B (it) * 1989-02-22 1992-01-28 Rotta Research Lab Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
DE69722610T2 (de) 1997-08-08 2004-04-29 Rotta Research Laboratorium S.P.A., Monza Neue Inhalationspräparate enthaltend CR 2039 (Andolast)
WO2000033831A1 (en) 1998-12-08 2000-06-15 Nutramax Laboratories, Inc. Combinations of st. john's wort and fatty acids
EP1196419B1 (en) * 1999-06-29 2003-09-24 Neurosearch A/S Potassium channel blocking agents
WO2002096463A1 (en) * 2001-05-25 2002-12-05 Pfizer Inc. A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
US7713964B2 (en) * 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US7244756B2 (en) * 2002-06-26 2007-07-17 Poseidon Pharmaceuticals A/S Benzimidazol-2-one derivatives and their use
EP1773325A4 (en) * 2004-06-14 2007-11-07 Sepracor Inc METHODS OF USING ALBUTEROL AND AGENTS INDUCING THE OPENING OF POTASSIUM CHANNELS ACTIVATED BY CALCIUM

Also Published As

Publication number Publication date
US20060052427A1 (en) 2006-03-09
DK1634595T3 (da) 2008-11-24
PT1634595E (pt) 2008-08-28
JP2006056890A (ja) 2006-03-02
JP4987268B2 (ja) 2012-07-25
US7482371B2 (en) 2009-01-27
CA2514373A1 (en) 2006-02-19
PL1634595T3 (pl) 2009-01-30
DE602004015788D1 (de) 2008-09-25
CA2514373C (en) 2012-07-10
AU2005203706A1 (en) 2006-03-09
EP1634595B1 (en) 2008-08-13
ES2311771T3 (es) 2009-02-16
ATE404195T1 (de) 2008-08-15
EP1634595A1 (en) 2006-03-15
AU2005203706B2 (en) 2011-04-14

Similar Documents

Publication Publication Date Title
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
WO2005044192A3 (en) Triazole compounds and uses related thereto
UA102517C2 (ru) Замещенные производные морфолина и тиоморфолина, фармацевтическая композиция на их основе и их применение для производства лекарственного средства для лечения расстройства или заболевания центральной нервной системы
WO2008019967A3 (en) Phenyl, pyridine and quinoline derivatives
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
WO2008046087A3 (en) Spiro compounds and their uses as therapeutic agents
TW200728307A (en) Novel spirochromanone derivatives
WO2007060140A3 (en) Inhibitors of diacyglycerol acyltransferase (dgat)
WO2006046039A3 (en) Tetracyclic indole derivatives as antiviral agents
WO2008020040A3 (en) 2,5-dihydroxybenzene compounds for the treatment of fibrosis
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
NO20064010L (no) Indazolderivater og farmasoytiske preparater inneholdelse slike
WO2007009723A3 (en) Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments
WO2005080352A3 (en) Quinazoline derivatives and therapeutic use thereof
EA200801909A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
EP1714961A4 (en) INDAZOL COMPOUND AND THEIR PHARMACEUTICAL USE
WO2007002764A3 (en) Di-substituted oxadiazoles as cxc-chemokine receptor ligands
WO2008092072A3 (en) Modulators of the metabotropic glutamate receptor subtype 5 and uses thereof
NO20065551L (no) Anvendelse av opoid reseptor antagonistforbindelser for forhindring og/eller behandling av sykdommer assosiert med malet calcineurin
PT1634595E (pt) Derivados de n-fenilbenzamida como fármacos para o tratamento doença pulmonar obstativa crónica (dpoc)
MX2009007038A (es) Derivados de mononitrato de isosorbida para el tratamiento de trastornos intestinales.
TW200626158A (en) Naphthaline derivatives
EA200800071A1 (ru) Производные бензофуранила как ингибиторы 5-нт6-рецептора
WO2006079077A3 (en) Use of diltiazem or analogs thereof as modulators of ghrelin receptor
NO20051901L (no) Nye antimycobakterielle sammensetninger og pyrrole derivater som antimycobakterielle sammensetninger